Lipid A-core glycan of bacterial lipopolysaccharide (LPS Lipid A-core)

The Lipid A-core glycan is a fundamental structural component of the lipopolysaccharide (LPS) found in the outer membrane of Gram-negative bacteria. It consists of Lipid A, a highly conserved hydrophobic anchor responsible for the molecule's endotoxic activity, and a core oligosaccharide that provides structural stability (Raetz & Whitfield, 2002). Biologically, this molecule is essential for bacterial viability and serves as a potent pathogen-associated molecular pattern (PAMP) that triggers the host's innate immune response via the Toll-like receptor 4 (TLR4) complex (Park & Lee, 2013). In clinical settings, the Lipid A-core is a critical driver of sepsis and septic shock, as its systemic release leads to an overwhelming inflammatory response (Hotchkiss et al., 2016). Therapeutic strategies targeting this molecule include the use of polymyxin antibiotics, which disrupt the bacterial membrane by binding to the Lipid A-core, and experimental neutralizing antibodies or enzymes designed to mitigate endotoxin-induced toxicity (Poirel et al., 2017). Despite its importance, targeting the Lipid A-core remains challenging due to the risk of toxicity from the drugs themselves and the complex dynamics of endotoxin release during infection.

Other names

EndotoxinLipid A-core oligosaccharideLPS Lipid A-coreLipopolysaccharide Lipid A-coreGram-negative bacterial endotoxin

Drugs targeting the Lipid A-core glycan, such as polymyxins, act by binding to the negatively charged phosphate groups of Lipid A and the core oligosaccharide through electrostatic interactions. This binding displaces essential divalent cations (Ca2+ and Mg2+) that stabilize the outer membrane, leading to increased membrane permeability, leakage of cytoplasmic contents, and bacterial cell death (Poirel et al., 2017). Other therapeutic approaches involve neutralizing the Lipid A moiety to prevent its interaction with the MD-2/TLR4 receptor complex, thereby inhibiting the pro-inflammatory signaling cascade that leads to septic shock (Park & Lee, 2013).